Axtria vs ConcertAI
Side-by-side comparison of AI visibility scores, market position, and capabilities
Axtria delivers AI-powered analytics and commercial software to 16 of the top 20 global life sciences companies; recognized in two Gartner Hype Cycle reports for 2025, acquired Conexus Solutions in April 2026.
About
Axtria is a global data analytics and software technology company exclusively focused on the life sciences industry, providing AI-powered solutions for commercial operations, advanced analytics, and cloud-based data management for pharmaceutical, biotechnology, and medical device companies. Its integrated platform — Axtria InsightsMAx.ai — combines SalesIQ for field force effectiveness, CustomerIQ for next-best-action engagement, MarketingIQ for commercial investment optimization, and DataMAx for data integration and governance, enabling life sciences companies to coordinate their commercial operations through a unified AI layer.
ConcertAI is an oncology AI and real-world data company at a $1.9B valuation — 5.5M multi-modal cancer RWD records, $230M+ raised, exiting FY2024 profitable with mid-teens EBITDA margins.
About
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates multi-modal patient data — including electronic health records, genomics, imaging, and pathology — from a network of oncology providers to support biopharma companies in clinical trial design, site selection, protocol optimization, patient matching, and regulatory submission.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.